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Sommario
Negli ultimi anni, parallelamente allo sviluppo di calcolatori elettronici
sempre più performanti, la fluidodinamica computazionale è diventa-
ta uno strumento di notevole utilità nell’analisi dei flussi. Si è inoltre
dimostrata di importante ausilio nello sviluppo di dispositivi medici.
Quando impiegate nello studio di flussi di fluidi fisiologici, come quello
del sangue, il vantaggio principale delle analisi CFD è che permettono
di caratterizzare il comportamento fluidodinamico senza dover eseguire
test in-vivo/in-vitro, consentendo quindi notevoli vantaggi in termini
di tempo, denaro e rischio derivante da applicazioni mediche. Inoltre,
simulazioni CFD offrono una precisa e dettagliata descrizione di ogni
parametro di interesse permettendo, già in fase di progettazione, di
prevedere quali modifiche al layout garantiranno maggiori vantaggi in
termini di funzionalità. Il presente lavoro di tesi si è posto l’obiettivo
di valutare, tramite simulazioni CFD, le performances fluidodinamiche
del comparto sangue “camera venosa” di un dispositivo medico monou-
so Bellco impiegato nella realizzazione di trattamenti di emodialisi. Al
fine di offrire al lettore una panoramica del contesto, il primo capitolo
dell’elaborato presenta una breve descrizione della disfunzione renale
e dei trattamenti sostitutivi. Notevole impegno è stato in seguito ri-
volto allo studio della letteratura scientifica in modo da definire un
modello reologico per il fluido non-Newtoniano preso in considerazione
e determinarne i parametri caratteristici. Il terzo capitolo presenta lo
stato dell’arte delle apparecchiature Bellco, rivolgendosi con particolare
attenzione al componente “cassette” del dispositivo monouso. L’ana-
lisi fluidodinamica del compartimento “camera venosa” della cassette,
che sarà presa in considerazione nei capitoli quinto e sesto, si inserisce
nell’ambito della riprogettazione del dispositivo attualmente in com-
mercio: il quarto capitolo si incentra sul suo nuovo design, ponendo
specifico interesse sul layout della camera venosa di nuova generazione.
Per lo studio dei flussi che si sviluppano internamente ad essa ci si è av-
valsi del modulo CFD del software COMSOL multiphysics R© (versione
5.0); la definizione del modello implementato e della tipologia di studio
effettuato sono presi in considerazione nel quinto capitolo. Le proble-
vi
matiche di maggior impatto nella realizzazione di un trattamento di
emodialisi sono l’emolisi e la coagulazione del sangue. Nell’evenienza
che si verifichino massivamente occorre infatti interrompere il tratta-
mento con notevoli disagi per il paziente, per questo devono essere
evitate. Nel sesto capitolo i risultati ottenuti sono stati esaminati ri-
volgendo particolare attenzione alla verifica dell’assenza di fenomeni
che possano portare alle problematiche suddette.
Abstract
In recent years, together with the development of more efficient com-
puter, Computational Fluid Dynamics (CFD) has become a consider-
ably useful tool in the analysis of flows. It has also proved to be of much
help in the development of medical devices. When used in the study of
physiological fluids flows, such as blood, the main advantage of CFD
analysis is that they allow the characterization of the fluid-dynamic
behavior without the need of in-vivo/in-vitro measurements, leading
to considerable benefits in terms of time, money and risk arising from
medical applications. In addition, CFD simulations offer an accurate
and detailed description of each parameter of interest. Starting from
the design phase, it is possible to predict what layout changes will lead
to greater advantages in terms of functionality. The present work has
the purpose of assessing, by means of CFD simulations, the fluid- dy-
namic performances of the blood compartment “venous chamber” of
a Bellco’s medical disposable device used in carrying out hemodialysis
treatments. In The first chapter, a brief description of kidney fail-
ure and its replacement therapy provides the reader an overview of
the context in which this thesis work has been developed. Consider-
able effort was then addressed to the study of the scientific literature,
so as to define a rheological model for the non-Newtonian fluid taken
into consideration and to determine its characteristic parameters. The
third chapter deals with the Bellco’s equipment state of the art, focus-
ing on the disposable device component ”cassette”. The fluid dynamic
analysis of the venous chamber of the cassette is part of the redesign of
the currently used device: the fourth chapter focuses on its new layout,
particularly that of the new venous chamber. The investigations on the
flows that develop inside the venous chamber were done using the CFD
module of the software COMSOL Multiphysics R© (version 5.0); the def-
inition of the implemented model and the type of study are taken into
account in the fifth chapter. The major problems during an extracor-
poreal dialysis treatment are blood hemolysis and coagulation. If they
occur massively, it is necessary to suspend the treatment, with con-
siderable troubles for the patient; therefore, they must be avoided. In
viii
the sixth chapter, the obtained results are examined focusing on check-
ing the absence of phenomena that can lead to the above-mentioned
problems.
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Chapter 1
Kidney Failure and Dialysis
This chapter introduces reader to renal failure and its replacement
therapy: dialysis.
Kidneys are two organs with the average size of a fist located in the
abdominal cavity (see Fig.1.1). Blood is transported to the kidneys
through the renal (arcuate) artery an returns to the heart through the
renal (arcuate) vein and the lower vena cava. Their main function is to
remove excess water and waste products of metabolism, such creatinine
and urea, from blood. Besides, they also maintain the homoeostasis of
electrolytes removing several salts and regulate the acid-base balance.
In addition, human kidneys perform a few endocrine and metabolic
functions, such as production of the hormone known as erythropoi-
etin and conversion of vitamin D to its active form [33]. Each kidney
contains about 1 million nephrons (see Fig.1.2), each nephron be-
ing capable of forming urine by itself. The nephron is composed of a
glomerulus (a capillary bed) through which fluid is filtered out of the
blood and a long tubule in which the filtered fluid is converted into
urine on its way to the pelvis of the kidney; from here two small tubes
called ureters carry the waste matter to the bladder, which expels the
urine through the urethra. [55].
1.1 Kidney Failure
Kidney failure is a medical condition in which the kidneys fail to per-
form their task adequately. This is mainly determined by a decrease
4 Kidney Failure and Dialysis
Figure 1.1: Representative image of a Kidney [8].
Figure 1.2: The Nephron and its components [62].
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in glomerular filtration rate (GFR) that is the rate at which blood is
filtered in the glomeruli of the kidneys; symptoms are a decrease in
or absence of urine production and determination of waste products
(creatinine or urea) in the blood. There may be also problem with in-
creased fluid in the body leading to swelling, raised levels of potassium,
decreased levels of calcium and in later stages anaemia. Long-term kid-
ney problems are also associated with increased risk of cardiovascular
disease [31].
Renal failure can be divided into two categories: acute kidney in-
jury, which is often reversible with adequate treatment, and chronic
kidney disease, which is often not reversible.
1.1.1 Acute Kidney Injury
Acute kidney injury (AKI) or acute renal failure (ARF) [6] is a rapidly
progressive loss of renal function generally characterized by a decrease
in urine production and fluid electrolyte imbalance [44]. AKI usu-
ally occurs when the blood supply to the kidneys is suddenly inter-
rupted (for example accidents, injuries or complications from surgeries
in which the kidneys are deprived of normal blood flow for extended
periods of time) or when the kidneys become overloaded with toxins
(drug overdose, chemotherapy). People suffering from acute kidney in-
jury require supportive treatment until their kidneys recover function,
and they often remain at increased risk of developing future kidney
failure [57].
1.1.2 Chronic Kidney Disease
Chronic kidney disease (CKD) is a progressive loss in renal function
over a period of months or years. The most common causes of CKD are
diabetes and long-term, uncontrolled hypertension [4]; overuse of com-
mon drugs such as ibuprofen and paracetamol can also cause chronic
kidney disease [34]. Some infectious disease, such as Hantavirus and
HIV, can attack the kidneys, causing renal failure. Chronic kidney dis-
ease is identified by a blood test for creatinine, which is a breakdown
product of muscle metabolism. Higher levels of creatinine indicate a
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lower GFR and as a result a decreased capability of the kidneys to ex-
crete waste products. As summed-up in Tab.1.1, the severity of CKD
is measured in five stages, which are calculated using patient’s GFR
[16].
Stage 1 CKD is mildly diminished renal function with few symp-
toms; Stages 2 and 3 need increasing levels of supportive care from their
medical providers to slow and treat their renal dysfunction. Patients
in stages 4 and 5 usually require preparation of the patient towards
active treatment in order to survive. Stage 5 CKD, often-called end-
stage renal disease (ESRD), is considered a severe illness with poor life
expectancy if untreated and requires some form of renal replacement
therapy (dialysis) or kidney transplant whenever feasible.
Chronic kidney disease resulted in 956’000 deaths in 2013 up from
409’000 deaths in 1990 [17]. In 2012, patients reported under ESRD
were approximately 42’000 in Italy [63]; in Canada 1.9 to 2.3 million
people have CKD [2]. The U.S. Centers for Disease Control and pre-
vention found that CKD affected an estimated 16.87% of U.S. adults
aged 20 years and older, during 1999 to 2004 [18].
1.2 Treatment for End-Stage Renal Disease
There are several treatments for end-stage renal disease which allow
extending the life of the patients for some years, kidney transplantation
being the best alternative [52]. However, this option is limited by the
number of kidneys available and by the compatibility with the donor.
This way, dialysis treatments have to be done, where the function of
kidneys is mimicked artificially.
Table 1.1: GFR level for different CKD stage
CKD Stage GFR level(mL/min/1.73 m2)
Stage 1 ≥90
Stage 2 60 – 89
Stage 3 30 – 59
Stage 4 15 – 29
Stage 5 <15
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Dialysis is a process for removing waste and excess fluid from the
blood and is used primarily as an artificial replacement for lost kid-
ney function in people with kidney failure. The underlying principles
of dialysis is the diffusion of solutes and ultra-filtration of fluid across
a semi-permeable membrane. Diffusion is a property of substance in
water: they tend to move from an area of high concentration to an
area of low concentration. Blood flows by one side of a semi-permeable
membrane, and dialysate1, or special dialysis fluid, flows by the op-
posite side. A semi-permeable membrane is a thin layer of material
that contains holes of various sizes, or pores. Smaller solutes and fluid
pass through the membrane, but the membrane blocks the passage of
larger substances (for example, red blood cells, large proteins). This
replicates the filtering process that takes place in the kidneys, when
the blood enters the kidneys and the larger substances are separated
from the smaller ones in the glomerulus [41].
There exist different kinds of dialysis: peritoneal dialysis, hemodial-
ysis, hemofiltration and hemodiafiltration.
1.2.1 Peritoneal Dialysis
In peritoneal dialysis, the dialysate runs through a tube into the peri-
toneal cavity2 where the peritoneum acts as a partially permeable mem-
brane. Diffusion and osmosis drive waste products and excess fluid
through the peritoneum into the dialysate until it approaches equilib-
rium with the body’s fluids. Then the dialysate is drained, discarded,
and replaced with fresh dialysate [32]. A schematic view of a peritoneal
dialysis treatment is summed in Fig. 1.3.
1.2.2 Hemodialysis (HD)
In hemodialysis blood is pumped out of the body to an external filter,
called dialyzer, where it flows in the lumen of thousands of tiny hol-
1Dialysate: a chemical bath used in dialysis to draw fluids and toxins out of the
bloodstream and supply electrolytes and other chemicals to the bloodstream [25].
2Peritoneal cavity : a potential space between the parietal peritoneum and visceral
peritoneum [54], that is, the two layer of tissue containing blood vessels that lines and
surrounds the abdominal cavity and the relatives internal organs (stomach, spleen, liver,
intestine) [7].
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low fibres membranes (0.4 – 2.6 m2 surface area) while the dialysate
counter-flows in the dialyzer’s shell. The hollow fibre membrane acts
as a barrier that retains blood proteins and cells, while removing low
molecular weight waste metabolites from the blood to the dialysate
[1]. The counter-current flow of the blood and the dialysate maximizes
the concentration gradient of solutes between the blood and dialysate,
which help remove more toxins from the blood. The concentrations of
solutes are high in the blood, but low or absent in the dialysis solution
and constant replacement of the dialysate ensure that the concentra-
tion of undesired solutes is kept low on this side of the membrane. In
order to prevent the depletion of the blood electrolytes, the dialysate
should contain a similar concentration of minerals like potassium and
calcium. This treatment is very effective removing small uremic toxins,
but for larger toxins the removal is low, due to the sieving properties
of the membrane. For the filtration of excess water, a transmembrane
pressure difference can be applied, controlling easily the amount of wa-
ter removed [13]. After filtration, the cleansed blood is returned via
the circuit back to the patient’s body (see Fig.1.4).
Hemodialysis is the most common treatment for end stage renal
disease, with nearly 1,4 million uretic patients treated worldwide in
2004 [13].
1.2.3 Hemofiltration (HF)
Hemofiltration is a similar treatment to hemodialysis, but it works
according to a different principle. The blood is pumped through a dia-
lyzer as in hemodialysis but no dialysate is used. A pressure gradient -
called transmembrane pressure - is applied and, as a result, water and
solute move across the ultrafiltration membrane by a convective mech-
anism (see Fig.1.5). Hemofiltration membranes are usually 10 times
more permeable to plasma water than the membrane for hemodialysis;
however, they should be capable of retaining the blood proteins and
cells [13] as well.
Since the main mechanism of removal is convection, dissolved sub-
stances with large molecular weight, which are not cleared as well in
hemodialysis, are filtered. On the other hand, small molecules are just
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Figure 1.3: Schematic of a peritoneal dialysis treatment [64].
Figure 1.4: Schematic of a hemodialysis treatment [61]
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dragged from the water flux, the concentration in the filtrate being
similar to tat of the plasma. This implies that the removal of small
molecules is not as efficient as in the hemodialysis [13].
Due to higher plasma water loss, the ultrafiltrate produced has to
be completely or partially replaced by a replacement fluid containing
electrolytes. The replacement fluid can be introduced in the blood
upstream (pre-dilution), downstream (post-dilution) or in both at the
same time [13] [28].
1.2.4 Hemodiafiltration (HDF)
Hemodiafiltration is a combination of the treatments hemodialysis and
hemofiltration [23]. To improve the poor removal of low molecular
weight solutes in hemofiltration, a dialysate fluid is circulated in the
counter-flow shell of a hemofilter originating a concentration gradient
that causes the diffusion of small molecular weight solutes out of the
blood [33]. On the other hand, the convective flow imposed in this
method results in a better deduction of the excess water and the higher
molecular weight toxins [23].
As in hemofiltration, a replacement fluid may be needed. This sub-
stitution fluid can also be administered either before, after or both
before and after the dialyzer. Both pre-dilution and post-dilution
have advantages and disadvantages: pre-dilution has the advantage
of decreasing blood viscosity and hemoconcentration preventing clot
formation in the membrane but has the disadvantage of diluting the
blood toxins, reducing their clearances [19]. On the other hand, dur-
ing post-dilution the higher hemoconcentration and viscosity enhance
diffusive flux (there is a higher concentration gradient between blood
and dialysate) but limit the convective flux achieving larger clearances
for low molecular weight and lowest clearances for medium molecular
weight toxins [21] [48].
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Figure 1.5: Difference between hemodialysis and hemofiltration [59]
Figure 1.6: Working principle of hemodiafiltration [65]

Chapter 2
Blood Rheology
In the previous chapter, kidney disease and its replacement therapy
were examined. It has been pointed out that in healthy people renal
function carries out toxins removal from blood circulating inside kid-
neys while in those with renal dysfunction, blood is cleaned through a
hemofilter. It is therefore necessary to detail the physical properties of
blood that define its fluid dynamics performance characteristics. The
aim of this chapter is to introduce the vast field of blood rheology1,
and define the model and the relative parameters that shall be used
in the simulation. Moreover, the final sections deal with the relations
between fluid-dynamic characteristics and problems associated with
blood extra-corporeal circulation, such as hemolysis and coagulation.
To this aim, this chapter deals with:
• Blood compostion: whole blood consists of a suspension of 40-
50% by volume of small deformable bodies, mainly red cells in
the transparent plasma [55]. The rheological characteristics of
blood are determined by the properties of this components and
their interaction with each other as well as with the surrounding
structures [51];
• Physiological fluid dynamics and Hemorheology : while plasma is
1Rheology is the study of the flow of matter, primarily in a liquid state, but also as
‘soft solids’ or solids under conditions in which they respond with plastic flow rather than
deforming elastically in response to an applied force [49]. In particular Hemorheology
deals with the flow and deformation behaviour of blood and its formed elements (RBCs,
WBCs, platelets).
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generally treated as a Newtonian fluid, the behaviour of whole
blood is non-Newtonian hence is needed to define its non-Newtonian
rheological characteristics;
• Hemolisys : hemolysis refers to the breakdown of red blood cells
and the consequent release of hemoglobin in plasma. Conditions
that can cause hemolysis include immune reactions, toxins and
mechanical stresses (such as those deriving from hemodialysis);
• Coagulation: coagulation relates to the process by which a blood
clot is formed. It results from a complex cascade reaction, that
involves many ’clotting factors’, some always present in the blood
and some released from damaged tissue and platelets.
2.1 Blood composition
In order to acquire better understanding of the non-Newtonian behav-
ior of blood it is necessary to specify its components. Blood is about
7% of the human body weight. The normal adult has a blood volume
of about 5 litres [37]. Blood is a circulating heterogeneous multi-phase
mixture of formed elements (corpuscles or cells) suspended in a fluid
medium known as plasma (about 55% by volume; 2.7 - 3.0 litres in
a normal human). The formed elements (cells) consist of red blood
cells ‘RBCs’ (erythrocytes), white blood cells ‘WBCs’ (leukocytes) and
platelets (thrombocytes).The formed elements in blood consist of 95%
red blood cells, 0.13% white blood cells and about 4.9% platelets.
Plasma is a transparent, slightly yellowish, dilute electrolyte solu-
tion (almost 92% water) containing organic molecules, minerals and the
three major types of blood proteins: fibrinogen, globulin and albumin
[51] [55].
RBCs are produced in the bone marrow and consist of a concen-
trated solution of haemoglobin, an oxygen carrying protein, surrounded
by a flexible membrane. Their typical dimensions in humans are 7.8µm
in diameter and 2µm in thickness [55]. Their shape is that of bicon-
cave discoid, flexible enough to vary depending on the diameter of the
vessel through which blood is flowing. RBCs are the dominant partic-
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ulate matter in blood, numbering approximately 5 · 106 per mm3. The
percentage of blood volume made up by red cells is referred to as the
hematocrit. Hematocrit ranges from 42 to 45% in normal blood, and
plays a major role in determining the rheological properties of blood
[37].
WBCs are cells of the immune system which defend body against
both infectious disease and foreign materials. Several different type of
leukocytes exist and they are all produced in the bone marrow. Their
size vary from 6 to 22 µm. There are normally 104 white blood cells
per mm3 of blood, so that their volume concentration in the blood is
one white cell to every 1000 red cells, which is totally insignificant from
the rheological point of view [37] [55].
Platelets are cells fragments circulating in blood that are involved
in the cellular mechanism of haemostasis leading to the formation of
clots. Low levels of platelets predisposes to bleeding, while high levels
increase the risk of thrombosis (that is the coagulation of blood in the
heart or blood vessel). They are much smaller than red or white cells,
whit a diameter of 2-3 µm. Their number is one-tenth of the red cells
[37].
Figure 2.1: Simplified illustration of the main blood composition [51].
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2.2 Physiological fluid dynamics and Hemorheol-
ogy
Physiological fluid dynamics deals with flow of biological fluids, for
example, blood in a tube such as blood vessel. The involved phys-
ical quantities like velocity profiles, flow rates and pressures depend
on the nature of fluid and the existing internal forces; it is therefore
essential to understand the rheological properties of the fluid in the
presence of forces. The basic difference between the solid and the fluid
state is that the former may exert a restraining force on the displaced
plane inside the medium, while the latter is unable to sustain internal
forces. The concept of solidity and fluidity are idealizations that de-
scribe the behaviour of real materials in certain limiting cases. Figure
2.2 summarizes the types of rheological materials. In general, the be-
Figure 2.2: Rheological classification of materials [55].
haviour of real materials encompasses many intermediate properties of
those shown in the figure. A rigid solid does not deform under shear or
tangential force. An elastic medium deforms under stress but returns
to its original state when the stress is removed. An inviscid fluid has
zero viscosity which represent another extreme of a material. Bingham
plastic remains rigid when the shear stress is of smaller magnitude then
the yield value τ0 but flows like a Newtonian fluid when the shear stress
exceeds τ0 [55].
Blood’s rheological properties do not allow a clear classification ac-
cording to the scheme in figure 2.2: in fact many different methods exist
to describe its behaviour. In the next sections differences between New-
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tonian and non-Newtonian fluids are elucidated, then non-Newtonian
characteristics of blood are investigated and a constitutive equation is
chosen in order to describe blood flow behaviour.
2.2.1 Newtonian and non-Newtonian fluids
According with the categorization illustrated in figure 2.2, an inviscid
fluid is one that has no viscosity. With zero viscosity, the fluid offers
no resistance to shearing forces. Hence, all shear forces are zero during
flow and deformation of the fluid. However, all real fluids have finite
viscosity, and it is necessary to take into account the viscosity and the
related shear forces associated with its deformation. Real fluids are
also called viscous fluids. Considering only laminar flow conditions,
a shear stress - shear rate relationship is used to define the fluidity
of liquids. This relation reflects the internal resistance between fluid
layers (laminas) and thus reflects the viscosity of the fluid; the viscosity
of a liquid can be calculated by dividing the shear stress by the shear
rate.
From a rheological point of view, real fluids are classified into two
main categories. Newtonian fluids are characterized by the shear stress
τ , which is proportional to the shear strain γ̇ (also called shear rate).
The slope of the characteristic represents the viscosity coefficient µ
which is constant at a given temperature and pressure. τ refers to
the shear forces per unit area, while the rate of shear strain γ̇ signifies
the velocity decrease in the distance perpendicular to the direction of
flow. The shear stress - shear rate relationship can be described by the
equation
τ = −µγ̇ (2.1)
This is known as Newton’s law of viscosity, and fluids that behave in
this fashion are termed Newtonian fluids. There are, however, many
fluids whose rheological behaviour does not obey equation (2.1) and the
are referred to as non-Newtonian fluids. As stated in the introduction
of this chapter, while plasma acts like a Newtonian fluid, whole blood
is treated as non-Newtonian. Non-Newtonian fluids are those in which
the viscosity is not a constant but rather depends on the magnitude of
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either τ or γ̇. The slope of the shear stress - shear rate characteristic
calculated at any given point on the curve is called apparent viscosity,
µapp at that point, which reads
µapp = τ/γ̇
The apparent viscosity of a non-Newtonian fluid may decrease (shear
thinning behaviour) or increase (shear thickening behaviour) as the
shear rate is increased. Non-Newtonian fluids may also have a yield
stress below which there is a finite stress but the shear rate is zero (no
flow), resulting in an infinite value for apparent viscosity. Note that
for both classes of fluids, the viscosity depends on temperature and for
most fluids viscosity decrease with increasing temperature. All these
information are displayed in figure 2.3 and 2.4.
Figure 2.3: Shear stress / Shear Strain relationship for Newtonian and non-
Newtonian fluids [55].
2.2.2 Modeling blood
The apparent viscosity of blood depends on the viscosity of the plasma,
the hematocrit (Fig. 2.5), the shear rate (Fig.2.5), the narrowness of
the vessel in which it is flowing (the so called Fahraeus-Lindqvist effect,
Fig.2.6) and on the temperature. The dependence on the prevailing
shear rate and the Fahraeus-Lindqvist effect classify blood as a non-
Newtonian fluid. As mentioned in Section 2.1, most non-Newtonian
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Figure 2.4: Viscosity - Shear Rate relation for (a)Newtonian fluid; (b) Shear
thinning fluid; (c) Shear thickening fluid; [60].
effects originate from the RBCs due to their high concentration and
distinguished mechanical properties such as elasticity and ability to ag-
gregate forming three-dimensional structures at low deformation rates,
while the presence of white blood cells and platelets do not significantly
affect the viscosity of blood since they are present in such small pro-
portions. However, platelets play an important role in the formation
of blood clots which may severely interfere with the flow [37].
Human blood is a shear thinning fluid. At low shear rates the ap-
parent viscosity is high, whereas under high shear forces viscosity ap-
proaches an asymptotic value that correspond to blood viscosity when
considered as Newtonian fluid. This shear thinning rheology arises from
disaggregation of the red blood cells with increasing shear rate, indeed
the aggregation is mostly demonstrated at low shear rates and hence
non-Newtonian behaviour is more pronounced at these regimes of low
deformation. The relationship between shear stress - shear rates for a
sample of human blood is shown in figure 2.7. As can be noticed, the
non-Newtonian region is below 100sec−1 of shear strain rate; at higher
γ̇ the viscosity of blood is relatively insensitive to further increase of
shear. For that reason there seems to be a general consensus that for
γ̇ > 100 s−1 blood can be considered as Newtonian [5], [24], [39], [40],
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Figure 2.5: (a)Effect of hematocrit on blood viscosity; (b)Human blood
viscosity as a function of shear rate for a range of hematocrit concentrations;
[5],[51]
Figure 2.6: Effect of tube diameter on apparent viscosity of blood for H =
40% T = 38◦C [55]. (1cp = 10−3Pa · s)
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[46], [51]. Many empirical equations and models have been proposed in
the last few decades to express this relation between τ and γ̇, however
there is none universally accepted. The most commonly used are the
Casson model [3], [37], [51], and the Carreau-Yasuda model [3], [24],
[27], [45], [51], which are briefly explained in the following paragraphs.
Figure 2.7: τ plotted vs. γ̇ for H = 40%, T = 37◦C. Note confusion of
points near origin [40]. (1dynes/cm2 = 0.1Pa · s)
Casson rheology model is a modified Bingham plastic model in
which blood is considered rigid when the shear stress is of smaller
magnitude than a yield stress τ0 but flows like a Newtonian fluid when
τ > τ0. It is normally used when the non-Newtonian feature to high-
light is the presence of the yield stress. The general expression is
√
τ = Kc
√
γ̇ +
√
τ0 (2.2)
where
Kc is the Casson viscosity coefficient (a non-dimensional quantity);
τ0 is the yield stress, function of the hematocrit.
According to the definition of Bingham plastic, γ̇ is zero if τ < τ0.
Figure 2.8 represent the so called ‘Casson plot’, a double square root
plot of shear stress vs. shear rate.
The Carreau-Yasuda model is used to emphasise the shear thin-
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Figure 2.8: Square root of shear stress plotted versus square root of shear
rate (H = 40%; T = 37◦C). Note the determination of square root of yield
stress τ0 by linear extrapolation [40].(1dynes/cm
2 = 0.1Pa · s)
ning feature of blood flow. It suggests the following equation which
incorporates two limiting viscosity:
µ(γ̇) = µ∞ + (µ0 − µ∞)[1 + (λγ̇)a](
n−1
a
) (2.3)
where
µ0 is the zero-shear-rate viscosity;
µ∞ is the infinite-shear-rate viscosity;
λ, a and n < 1 (shear thinning index) are curve fitting parameters
that define the transition region. The parameters a and n are non-
dimensional, the parameter λ has dimensions of time.
The main advantage of the Carreau-Yasuda model over other non-
Newtonian blood models is that it is continuous for all γ̇ ≥ 0. We note
that
lim
γ̇→0
µ(γ̇) = µ0 lim
γ̇→∞
µ(γ̇) = µ∞ (2.4)
indicating that at high shear rates the fluid acts as Newtonian with vis-
cosity µ∞, whereas at low shear rates, the fluid acts as non-Newtonian
with viscosity µ0. This model is normally used in numerical modelling
schemes thanks to its easier implementation due to its continuity [9].
In this work, it is needed to emphasize the shear thinning property
of blood, so the Carreau-Yasuda model is chosen. The chosen values for
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the parameters that define Equation 2.3 will be presented in chapter 5.
2.3 Haemolisys
Hemolysis refers to the loss, that is, damage of red blood cells [55].
Hemolysis has been thought to be of many origins, including the ef-
fect of solid surface interaction, shear stress and high negative pressure
gradients [38]. In normal human circulation system, the motion and
resulting forces acting on blood components do not destroy them (typ-
ical values of the wall shear stress in the normal circulation are found
in the range 1-3 Pa), but may even facilitate their function. However,
in some diseased state or when circulating in a foreign body (like a
hemodialysis circuit), the destruction of blood components occurs and
their orderly recycling process is altered. The occurrence of hemoly-
sis is evidenced by elevated serum hemoglobin and the appearance of
fragmented cells in the circulating blood called ‘ghost cells’.
Many studies have been made on hemolysis, hypotheses have been
proposed to explain the mechanism and threshold values for both the
shear stress (τt) and negative pressure gradient (∆P ) for extensive
erythrocytes damage have been identified. Referring to the shear stress,
three classes of hemolysis have been identified:
• Wall-red blood cells interaction(τt <150 Pa): cells that are in
physical contact with surfaces are mechanically torn or collapse
upon themselves so that modification on their morphology are
produced. In this regime of relatively low stresses there is little
damage, dependent on the surface condition and contact duration.
• Prolonged intermediate shear stress (τt >150 Pa): cells become
distorted in such a way that their membrane collapse upon them-
selves. Shear stress > 150 Pa represents the threshold value above
which occurs extensive cell damage and high rates of hemolysis
are find.
• Short duration high shear stress (in excess of 4000 Pa): this hemol-
ysis is caused by the yield stress of the cell membrane being ex-
ceeded. In this regime of stress extensive hemolysis occurs.
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Considering pressure gradient, Nevaril et al. [43] established that
pressure drop of the rate of ∆P < 22 · 106 Pa/sec produce little or no
red cell trauma.
Table 2.1: Threshold level of τt > in laminar flow for RBCs damage and
corresponding estimated exposure time from selected literature
Threshold level of τt
(Pa)
Order of magnitude of
exposure time (s)
References
300 120 Nevaril et al. [43]
150 120 Leverett et al. [38]
150-250 120 Sutera [53]
150 120 Krishna et al. [35]
2.4 Coagulation
Coagulation, or thrombosis, refers to the formation of clots in any part
of the system in which blood is circulating. The thrombus lump or
clot is an aggregate of blood elements that originates a 3D structure.
Thromboembolic conditions are linked to the fluid mechanical proper-
ties of blood flow and to the properties of the material of the circuit in
which blood flows. Causes can be summed as:
• Shear stress : since stress is a natural activator of platelets, dur-
ing relatively high shear stress, problems like platelets deposition
and thrombosis onto biomaterials are of remarkable importance.
Platelet activation, and as a consequence stable aggregation, oc-
curs above 8 Pa [26] [42].
• Shear rate: the effect of shear rate on coagulation is still un-
der investigation but many studies indicate that low shear rates
could promote the initiation of thrombosis by reducing the re-
moval of activated coagulation factors from surfaces. Low shear
rates have also been found to increase fibrin deposition, which is
a protein involved in blood clotting. Clinically, these hypothe-
ses seem confirmed by the fact that stasis and low blood flow
are considered risk factor for vein thrombosis. Moreover, at very
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low shear rate conditions, such as those associated with stagna-
tions zones, the fluid shearing forces of blood are not sufficient
to overwhelm the forces associated with cell-cell interaction, so
that, stable interaction between blood cells can be observed in
these low shear environments. Investigations on the existence of
a shear rate threshold value for the presence of coagulation have
led Hirsch et al. [30], in 1968, to suggest γ̇ ' 46sec−1 as a lower
limit for the absence of coagulation. Recent studies carried out
by Shen et al. [50] propose a threshold of γ̇ ' 20sec−1.
• Surface contact : all surfaces other than the undamaged vascular
wall endothelium induce a sequence of processes that results in
thrombus formation. When blood comes in contact with a for-
eign material, such as biomaterials, the first clinically manifest
process that occurs is the activation of haemostasis. The study
of this contribute lie outside the scope of this thesis and, as a
consequence, in the next studies it won’t be considered.

Chapter 3
Bellco’s Monitor and
Bloodlines state of the art
This chapter traces an introduction regarding Bellco’s hemodialysis
machine and bloodlines that are currently produced and commercial-
ized. In the final section, considerations that led to re-design of the
disposable ‘Cassette’ are described.
3.1 Hemodialysis machine
A ‘hemodialysis machine’ or ‘monitor’ is a device that allows a dialysis
treatment to be carried out once the functional parameters are defined.
Generally, the tasks of a hemodialysis machine are:
• to convey blood to the filter and returns it to the patient;
• to provide for the supply of dialysate;
• to adjust the fluid exchange between blood and dialysate;
• to verify the proper running of a treatment by monitoring given
variables (i.e. blood and dialysate pressures inside lines);
• to monitor the effectiveness of treatments;
Dialysis treatments in extra-corporeal circuit can be performed with
different kinds of monitors. It is possible to operate a distinction as
schematically shown in Figure 3.1.
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Figure 3.1: Distinction between the different type of monitors
Both on-line monitors and off-line monitors exist; this division is
based on the production method of the dialysate. In short, an on-line
monitor is directly connected to the feedwater wastewater pipes of the
host building in which is located and is provided with internal circuits
and ultrafilters able to generate the dialysate. An off-line monitor uses
pre-filled bags of fresh dialysate and empty bags to drain the spent
dialysate. The second differentiation is between Captive and Stan-
dard monitors. A Captive hemodialysis machine is able to carry out a
treatment only via a custom disposable device specific for that model:
dialysis is carried out only if the monitor recognizes the form of the de-
vice. A Standard monitor performs dialysis treatment using disposable
device with a standard layout marketed by any manufacturer (device’s
structure must be compatible with the pressure reading tools of the
monitor).
Bellco’s hemodialysis machines differ according to the type of pa-
tient to treat:
• Acute Patients :
- Amplya R© (Offline, Captive): it is a multitherapeutic system
for critical care capable of performing a vast number of ex-
tracorporeal blood treatments with one single circuit. For
each specific disease, Amplya R© offers an integrated and per-
sonalized therapeutic approach that can aid patient survival
and improve their quality of life.
• Neonatal Patients :
- Carpediem R© (Offline, Captive): smaller patients have until
today not been able to count on personalized treatments,
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especially with regard to fluid balance. Carpediem R© is the
only device on the market that offers specific neonatal treat-
ments: miniature and portable, it responds to the safety and
efficacy requirements for renal replacement therapies in such
patients.
• Chronic Patients :
- Formula R© (Offline, Standard): it was mainly used until the
introduction of the monitor Flexya R© in 2012.
- Flexya R© (Online, Captive): it is a monitor that allows ad-
ministering the largest possible number of dialysis treatments,
so as to offer to each patient the best possible therapy.
Monitors ‘Amplya R©’ and ‘Flexya R©’ interface with the Captive dis-
posable device examined in this thesis work. For that reason, Figure
3.2 shows, as example, the monitor ‘Flexya R©’ and its main components.
Numbered components are listed in Table 3.1.
Figure 3.2: Front view of Bellco’s monitor Flexya R©.
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Table 3.1: List of Flexya R©’s Components
Number Corresponding Component
1 Display
2 Dialysate connectors
3 Gripper for dialyzer positioning
4 Bicarbonate connector
5 Acid solution connector
6 Connector for dialysate infusion
7 Infusion line clamp
8 Level detector
9 Potentiometer
10 Connector for venous bloodline
11 Connector for arterial bloodline
12 Venous line clamp
13 Arterial line clamp
14 Heparin pump
15 Heparin pump
The frontal hematic panel is made up of (zoomed in Fig.3.3):
• Peristaltic pump: designated for the generation of fluxes, they are
distinguished in arterial pump, venous pump and infusion pump;
• Actuator-Sensor ‘Cassette Group’ : pressure sensors, cassette’s
latching and locking mechanism, disposable identification cam-
era.
3.2 Bloodlines currently in use
Once the main component and function of a hemodialysis machine have
been described, it is worth noting that, in order to perform a dialysis
treatment, they have to be connected to the bloodlines (hemodialyzer
and disposable device). The next paragraphs describes with Bellco’s
bloodlines main components and functions.
3.2.1 Dialyzer
The dialyzer is the central component of the hemodialysis system:
blood purification, that is the goal of a dialysis treatment, occurs in-
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Figure 3.3: Flexya R©’s frontal hematic panel.
side it. The blood compartment of the dialyzer is no longer monolithic
nowadays, rather it is composed of thousands of semi-permeable cap-
illaries (diameter of about 200µm) called ‘fibres’. Blood and dialysate
flow on the two sides of the semi-permeable fibers in a countercurrent
manner. It is the dialyzer membrane (formed by the fibres) that ba-
sically decides which molecules are retained in the blood stream and
which diffuse to the dialysate side: several kind of filters exist which are
based on this membrane filtering characteristic. Dialyzers differ in their
dimensions and number of fibres. In turn, fibres differentiate depending
on the material with which they are manufactured (polyethersulfone,
poly-amide, polymethylmethacrylate and other) and on the size of their
pores. A complete dialyzer is made up of the fibres bundle inserted into
a cylindrical plastic case (see Fig.3.4).
Bellco’s dialyzers contain from ∼ 5000 to ∼ 12000 fibres made of
polyethersulfone and, based on the size of the membranes’ pores, are
distinguished in High-Flux and Low-Flux. The cylindrical plastic case
is made of polycarbonate (a polypropylene alternative is under devel-
opment, see Fig.3.6).
In order to ensure and adequate purification of blood, typical blood
fluxes are of the order of 300mL·min−1, dialysate flux of 500mL·min−1.
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Figure 3.4: Typical Bellco’s dialyzer; indicated blood inlet and outlet,
dialysate inlet and outlet.
Figure 3.5: Example of uncapped dialyzer.
3.2.2 Cassette
Prior to the release of the monitor Flexya R© in 2012, the bloodline was
very simple and composed of separated arterial and venous lines, each
provided in a separate blister. Furthermore, the monitor-bloodline cou-
pling only allowed the implementation of standard treatments. Until
2012, Bellco’s hemodialysis machine for chronic patients was the mon-
itor ‘Formula R©’ (of which many variations exist) and an example of
its bloodline for a standard bicarbonate dialysis (BHD) is shown in
fig.3.7. This kind of monitor-bloodline coupling presents the following
limitations:
- impossibility to perform customized treatments, specific to the
needs of the patient;
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(a) Polycarbonate case.
(b) Polypropylene case.
Figure 3.6: Plastic case of dialyzer
- bloodlines assembly requires time and manual dexterity of the
operator.
In order to remove these disadvantages and because of the need to
develop new products to penetrate the market, in 2012 the monitor
Flexya R© was introduced. For the purpose of executing a dialysis treat-
ment, Flexya R© makes use of a bloodline characterized by the presence
of the cassette. Thanks to this new monitor-cassette coupling, the
following requirements of the marketing division have been satisfied:
- execution of 14 different kinds of treatment, customized to pa-
tient’s needs;
- quick and automatic bloodline installation on the monitor (im-
proved ergonomics).
The Flexya R© hemodialysis machine has already been analyzed in sec.3.1.
Here the disposable is considered, which consists of:
• Cassette: the component that interfaces with the hematic frontal
panel of the hemodialysis machine;
• cuvette (hematocrit measuring instrument);
34 Bellco’s Monitor and Bloodlines state of the art
Figure 3.7: Example of BHD standard Formula R© bloodline.
• connectors;
• tubes (arteriosus line, venous line, infusion line).
The component of interest in the following is the cassette. The
cassette is a 5 cavities device, made of rigid thermoplastic material,
that can be schematized as in Fig.3.8.
Figure 3.8: General schematic of the ‘Cassette’. ‘Arterial’ means ‘before
dialyzer’, ‘venous’ stays for ‘after the dialyzer’.
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The operating principle of the cassette can be understood referring
to the arrows of Fig.3.8 that indicates the direction of the fluxes circu-
lating inside the device: blood is drawn from the arterial access of the
patient, enters the arteriosus compartment of the cassette and thanks
to the movement of the arterial peristaltic pump is directed to the di-
alyzer. Contemporary, dialysate is also drawn by the infusion pump
and directed to the hemofilter for the pre-dilution. Once filtration has
been carried out, the cleansed blood enters the venous chamber to-
gether with the dialysate flux generated by the venous pump for the
post-dilution and from here returns to the patient.
More exhaustively, the functions of the cassette are:
• blood and dialysate directioning;
• monitoring of blood and dialysate pressures during dialysis treat-
ment;
• deaeration of blood.
Cassette’s functions are carried out through the five cavities high-
lighted with letters in Figure 3.9:
Chamber A is the Arterial pre-pump blood chamber: fistula1
pressure measurement in order to monitor the effectiveness of
pumping, within the following range:
• Range: (-400; +200) mmHg;
• Maximum rating: (-400; +400) mmHg;
Chamber B is the Arterial post-pump blood chamber: pre-dialyzer
pressure measurement in order to monitor the absence of clogging
in the dialyzer, within the following range:
• Range: (-200; +800) mmHg;
• Maximum rating: (-400; +800) mmHg;
1Fistula: a type of vascular access for hemodialysis that consists in an artificial com-
munication, obtained via surgery, between an artery and a vein, in order to divert high
pressure arterial blood in the venous system so as to obtain adequate blood flow to carry
out dialysis treatment [11].
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Figure 3.9: CAD model for the cassette; letters indicate the various cham-
bers
Chamber C is the Infusion chamber: infusion negative pressure
measurement in hemodiafiltrative treatments, within the follow-
ing range:
• Range: (-400; +200) mmHg;
• Maximum rating: (-400; +800) mmHg;
Chamber D is the Infusion chamber: infusion positive pressure
measurement in hemodiafiltrative treatments, within the follow-
ing range:
• Range: (-200; +800) mmHg;
• Maximum rating: (-400; +800) mmHg;
Chamber V is the Venous chamber: allows blood deaeration and
enable venous infusion pressure measurements in order to monitor
to absence of clots, within the following range:
• Range: (-200; +500) mmHg;
• Maximum rating: (-400; +500) mmHg;
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Note that letter F in the Venous chamber indicates a small filter
that prevents the infusion to the patient of any impurities or clots.
Chambers A,B,C,D are used to monitor pressure during treatments.
Monitoring is paramount in order to achieve the maximum effectiveness
of dialysis: during a dialysis session, pressures must oscillate within
specific ranges. Pressure transduction is committed to concave, disc-
shaped, impervious membranes (see Fig.3.10) that divide the respective
chambers in two hermetically separate compartments: one contains liq-
uid (blood/dialysate) while in the other there is trapped air that serves
as control volume for the transducer (see Fig.3.11). Depending on the
pressure variations of the liquid in the respective compartment, the
membrane is stimulated to deform and transmit the pressure oscilla-
tions to the air control volume. This sequence liquid-membrane-control
volume represents the pressure transduction pathway (see Fig.3.12).
(a) Top view of membrane. (b) Bottom view of membrane.
Figure 3.10: Schematic of a membrane [22].
Depending on the type of measure (higher of lower that the preload-
pressure, that is equal to the atmospheric pressure), the membrane
must be placed with the concavity towards liquid compartment (nega-
tive pressure measurements) ot toward the air compartment (positive
pressure measurements), as summed in Fig.3.13 and Fig.3.14.
As mentioned before, the venous chamber ‘V’ is the only whose
main purpose is not just pressure monitoring. In fact, it makes deaer-
ation of blood possible. This function is paramount for patient safety.
During dialysis treatments, microemboli develop in the blood circuit:
if they are not trapped in the venous chamber, they can be returned
to patient’s vascular access (in the worst case, embolism can result in
patient death in the event that it affects an artery). Downstream the
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Figure 3.11: View of a sectioned chamber used for positive pressure mea-
surements.
Figure 3.12: Layout of the pressure transducion sequence [20].
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Figure 3.13: View of the correct placement of membranes inside cassette
Figure 3.14: Membranes positioning in chambers.
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venous chamber a supplementary air detector and a clamp are provided
as an additional safety measure.
Once cassette’s components and relative functions have been defined
, the currently used cassette is shown (Fig.3.15).
The materials of which i is made of are summarizeed in tab.3.2;while
Fig.3.16 and Fig.3.17 show its body and membranes respectively.
Table 3.2: Currently used materials
Component Material
Cassette’s body PVC
Membranes EPDM
PVC (polyvinyl chloride) is a biocompatible2 plastic material com-
monly used for the fabrication of medical disposable. Its main advan-
tages are:
• low cost;
• moulding and bonding ease;
• possibility to modulate its mechanical properties by adding ad-
ditives during the extrusion process (in the past, the most com-
monly used additives - plasticizers - were phthalates, ever since
banned for their toxicity, nowadays the more stable and non-toxic
terephthalates are used).
PVC does not possess good mechanical properties, thus, larger thick-
nesses are required in order to manufacture rigid components. Larger
thickness may cause problems in moulding and cooling of the parts.
Another unfavourable feature of PVC is its yellowing caused by ster-
ilization or ageing. For obvious reasons, yellow is not a likeable color
for a medical disposable: for that reason the currently used cassette
is doped with brighteners (antagonists to the yellow degradation prod-
ucts).
2Blood Compatibilty : when in contact with a living system, the material must not cause
adverse reactions that can compromise the ability to use it for as long as expected. Espe-
cially, an essential requirement for a haemocompatible material is its non-thrombogenicity
(must not encourage the formation of clots when in contact with blood) [66].
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(a) Front view.
(b) Rear view.
Figure 3.15: View of currently used cassette.
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(c) Isometric view.
(d) Venous Chamber detail.
Figure 3.15: Views of currently used cassette.
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(a) Front view of the PVC cassette’s body.
(b) Rear view of the PVC cassette’s body.
Figure 3.16: PVC cassette’s body.
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EPDM is a thermosetting elastomer made of ethylene, propylene
and a diene monomer. It is a haemocompatible material, suitable for
blood contact, characterized by good mechanical properties and gas
impermeability. An unfavourable characteristic is its black colour.
(a) Top view of EPDM membrane. (b) Bottom view of EPDM membrane.
Figure 3.17: EPDM membranes.
3.2.3 New Cassette’s Design Input Requirements
In the previous section, components and respective functions of the cur-
rently used cassette and the materials with which it is manufactured
have been described. Moreover, the main advantages and disadvan-
tages of both the PVC cassette’s body and the EPDM membranes
were highlighted. In the following section, the motivations that led to
the design of a new disposable, which are mainly linked to the choice
of new materials, are listed. They can be summarized as follows:
• reduction of manufacturing costs and time: the productive
process of the currently used cassette consists in molding for the
PVC cassette’s body and molding followed by vulcanization for
the EPDM membranes. These processing techniques, together
with part assembly, do not ensure process repeatability and ro-
bustness and, furthermore, are characterized by high production
costs and times. As will be seen in the next chapter, in order
to fulfil this input, new materials that allow co-moulding have
been chosen: this guarantees lesser production costs and times
and major robustness of the production process;
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• specific requirements for the new materials: chosen poly-
mers selected for the replacement of PVC and EPDM should
have similar mechanical properties, must be haemocompatible
and they must be transparent. All these properties must be ful-
filled even after sterilization (with beta or gamma ray) and ageing;
• disposable’s rigidity improvement;
• design manufacturing improvement;
• better removal of entrapped air: deaeration of circulating
blood is paramount both for patient safety and for a proper exe-
cution of the treatment;
• removal of elements that promote coagulation.

Chapter 4
Cassette New Design
In sec.3.2.2, components and main functions of the disposable were
examined. The one currently used was also shown and described. In
this chapter the new design of the cassette is presented and choices
that were made in order to satisfy the project inputs are clarified.
4.1 Geometry
First of all, it must be made clear that changes to the geometric layout
of the new cassette are limited by constraints imposed by the inter-
face between cassette and monitors. These constraints, illustrated in
Fig.4.1, are represented by:
• Constraints A: mutual positioning between the slots of the pump-
ing segment;
• Constraints B : mutual positioning between the slots of the pres-
sure transducer of the monitor.
Moreover, the new cassette must have the same number of ports (16, as
shown in Fig.4.2), in order to allow the implementation of all feasible
the treatments with the cassette currently used.
Figures 4.3 shows the layout of the new cassette.
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(a) Constraints A.
(b) Constraints B.
Figure 4.1: Currently used cassette; constraints indicated with letters.
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Figure 4.2: Currently used cassette; ports indicated by numbers.
4.2 Materials
The project inputs for the design of the new cassette mainly concern
the choice of the materials of which the cassette and the membranes are
manufactured. The fulfilment of the requirements explained in sec.3.2.3
led to the following choices.
• Cassette’s body: to replace PVC, the polymer PETG SKY-
GREEN S2008 was chosen (see Fig.4.4). PETG is obtained from
PET (polyethylene terephthalate) by addition of a glycol. This
results in improved workability, allowing the moulding of signifi-
cantly complex parts too. Furthermore, compared with the PET,
PETG melts more easily and shows less crystallization, resulting
in lower fragility, lower shrinkages but also in reduced resistance.
The strengths of PETG to PVC are:
- possibility of being co-moulded;
- excellent mechanical properties allowing lower thickness;
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(a) Front view.
(b) Rear view.
Figure 4.3: View of the new cassette.
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(c) Isometric view.
(d) Venous Chamber detail.
Figure 4.3: Views of the new cassette.
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(a) Front view.
(b) Rear view.
Figure 4.4: Photos of the PETG cassette.
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- high softening temperature allowing fast moulding (PETG
does not require long cooling times);
- excellent clarity and haze;
- PETG does not need the use of brighteners since it does not
turn yellow as a result of sterilization or ageing.
On the other hand, disadvantages of PETG in comparison to PVC
are:
- higher cost of raw material (abated by the possibility of co-
moulding);
- bonding problems with tubing due to its resistance to cyclo-
hexanone.
• Membranes: concerning the replacement of EPDM, a PE elas-
tomer manufactured by the German company ‘ACTEGA’was cho-
sen (see Fig.4.5). This elastomer has slightly worse mechanical
properties than the EPDM, but can be manufactured with co-
moulding and it is transparent (even after sterilization and age-
ing). In addition, experimental tests conducted in the company
laboratories have proved its satisfactory reliability and accuracy
as a pressure transducer.
(a) Top view of the ACTEGA mem-
brane.
(b) Bottom view of the ACTEGA mem-
brane.
Figure 4.5: ACTEGA membrane.
In summary, according to the project inputs requirements, the new
cassette shall be co-moulded and shall be produced faster that the
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one currently in use. It shall also be lighter and at the same time
less deformable, it shall be transparent and will not turn yellow. It is
also worth noting that the new disposable is characterized by colour
uniformity (see Fig.4.6), guaranteed by the transparency of both the
PETG-SKYGREEN and the elastomer-ACTEGA, unlike the currently
used ones (light blue PVC - black EPDM).
4.3 The Venous Chamber
The venous chamber is the cassette’s component that has been changed
most, owing to the fact that it should not directly satisfy the constraints
A and B (see fig.4.1); its only specifications concerns with the internal
volume, which shall not be increased. Changes that have been made,
together with reasons that led to their implementation, are summarized
below:
a) external profile modification: ensures greater rigidity, facili-
tates molding and ultrasonic welding of the cover;
b) reduction of the internal volume: in order to satisfy a re-
quest made by the marketing department (the internal volume
was decreased from 33,9mm3 to 27,5mm3, δV = −23%);
c) relocation of the venous infusion port: in-vitro tests high-
lighted that the proximity between the chamber walls and the
filer may enhance coagulation; for that reason the venous infu-
sion port, and so the filter, has been relocated in the center of the
chamber, where the distance between walls and filter is maximum;
d) addition of the inlet duct: its insertion improves fluxes direc-
tion and increases recirculation;
e) bulkhead removal: its presence caused the occurrence of re-
circulation zones; it has been removed since now this function is
carried out by the inlet duct and in order to decrease the surface
that is in contact with blood;
f) relocation of the heparin infusion port: molding require-
ment;
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(a) Currently used cassette
(b) New cassette.
Figure 4.6: Differences between colours uniformity in the currently used
disposable and in the new ones.
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All these modifications are summarized in Fig.4.7 where each let-
ter corresponds to the respective change. In the next chapters, the
fluid dynamic efficacy of the new design of the venous chamber is anal-
ysed, with the aim of investigating the possible presence of favourable
conditions to the occurrence of hemolysis and coagulation.
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(a) CV of the currently used cassette
(b) CV of the new cassette
Figure 4.7: Comparison between the venous chambers.

Chapter 5
Numerical Simulations
This section covers the approach of the CFD simulations. The first
part contains general theory regarding fluid dynamics (in particular
Hemodynamics, which is he study of blood flow in biomechanical sys-
tems) and CFD, such as the Navier-Stokes equations, and regarding
the Finite Element Method, which is the one employed by COMSOL.
The latter part involves the CFD simulations in COMSOL, where the
settings are explained in steps and the methods are motivated.
5.1 Hemodynamics
Hemodynamics is the study of blood flow in biomechanical systems.
It is a complicated science principally due to the composition of blood
(plasma and formed elements) which makes it behave like a non-Newtonian
fluid. For many hemodynamics study, approximations are made in or-
der to apply simple fluid dynamics relations to describe blood flows.
However, in this thesis blood is considered as an incompressible non-
Newtonian fluid. This means that local density variations are neglected
but that the shear thinning feature, that is the main non-Newtonian
characteristic of blood, is taken into account using the Carreau-Yasuda
model.
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Figure 5.1: (a)Reynolds’ experiment using water in a pipe to study transition
to turbulence; (b)Typical dye streake [36]
5.1.1 The Reynolds Number
As a natural phenomenon in fluids, the characteristic of the flow can
change drastically under certain conditions, for example at high enough
velocities. Various quantities can be used to characterize flow in dif-
ferent situations. The Reynolds number is one of these fundamental
parameters of the fluid dynamics that allow to mark out the type of
flow [10]. This non-dimensional quantity was named after Osborne
Reynolds (1842 - 1912) who investigated experimentally (apparatus
in Fig.5.1) the transition of flow from the orderly kind that we call
‘laminar flow’to the more chaotic type termed ‘turbulent flow’. It was
known from earlier studies that turbulent flow occurs in conduits of
large cross-sectional dimensions and flows at high velocities, whereas
laminar flow occurs in slow flows in conduits of relatively small cross-
sectional dimensions. The role of viscosity and density in affecting the
type of motion was not as well-characterized.
Reynolds established that the change in the nature of the flow occurs
when a certain combination of the parameters in the flow crosses a
threshold. This combination, that is the ‘Reynolds Number ’is defined
as follow.
Re =
ρUL
µ
=
UL
ν
(5.1)
where
ρ is the fluid density;
µ is the dynamic viscosity of the fluid;
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ν = µ
ρ
is the kinematic viscosity;
U is the mean velocity of the fluid;
L is the typical length scale of the flow (e.g. the hydraulic diameter
for pipe flow).
We can ascribe a certain physical significance to the Reynolds num-
ber. This is most conveniently seen by recasting this group after mul-
tiplying both the numerator and the denominator by the mean flow
velocity U. In fact, this leads to
Re =
ρU2
µ(U/D)
(5.2)
In this form, we see that the denominator represents a characteristic
shear stress in the flow, because it is the product of the viscosity of the
fluid and a characteristic velocity gradient obtained by dividing the av-
erage velocity by the diameter of the tube. The numerator, in contrast,
describes an inertial stress; recall that the larger the density, the more
massive a material is, and mass is a measure of inertia. This is the rea-
son for calling the product ρU2 a characteristic inertial stress. Thus,
we can think of the Reynolds number as the ratio of two characteristic
stresses in the flow:
Re =
InertialStress
V iscousStress
(5.3)
Stress is force per unit area , therefore it is common to express the
physical significance of the Reynolds Number as:
Re =
InertialForces
V iscousForces
(5.4)
We see now that the nature of the flow in a tube, whether laminar
or turbulent, depends on the relative importance of the inertial forces
in comparison with the viscous forces. At low values of the Reynolds
number, the viscous forces are relatively more important, and distur-
bances in the flow are damped out by viscosity. This results in a flow
characterized by smooth and organized layer motion. Flow of this kind
is said to be in the laminar regime. On the other hand, at higher val-
ues of the Reynolds number, inertial forces dominate the viscous forces
so that the damping of disturbances by viscosity is less effective. This
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kind of flow is characterized by the presence of chaotic eddies, vortices
and other flow instabilities of widely different length and time scales
[58]. In this regime the flow is referred to as turbulent and is much
more difficult to predict. At moderately high Reynolds numbers, the
flow starts changing from laminar to turbulent. This regime is known
as the transitional regime, where the flow might show characteristic of
both laminar and turbulent flow. For a cylindrical pipe, the transition
from laminar to turbulent flow usually occurs for Re slightly above
2100 (see Tab. 5.1) but it depends on problem specifics such as surface
roughness and geometry variations [55], [36].
Table 5.1: Flow characterization within a pipe by the Reynolds number
Reynolds number Flow regime
Re < 2100 Laminar flow
2100 < Re < 4000 Transitional regime
Re > 4000 Turbulent regime
5.1.2 Velocity Profile
For fluid flow within a pipe, the velocity profile is an important property
of interest. The fluid velocity in a pipe changes from zero at the surface
because of the no-slip condition (see 5.1.4) to a maximum at the pipe
centre. Usually it is convenient to work with an average velocity Uav,
which remains constant in incompressible flow when the cross-sectional
area of the pipe is constant (Fig. 5.2) while in some applications it is
necessary to find out the velocity value as a function of the cylindrical
coordinates r.
The value of the average velocity Uav at some streamwise cross-
section is determined from the requirement that the conservation of
mass principle (see sec.5.1.3) must be satisfied, that for incompressible
fluids in leads to
ṁ = ρUavAc =
∫
Ac
ρu(r) dAc = const (5.5)
where
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Figure 5.2: Velocity profile within a circular pipe.
ρ is the fluid density;
ṁ is the mass flow rate;
Ac is the cross-sectional area;
u(r) is the velocity profile.
The velocity profile, for fully developed laminar flow in a cylindrical
pipe with constant diameter, can be derived directly by fundamental
principle of fluid flow (Poiseuille flow) and is given by eq.5.6
u(r) = 2Uav
[
1−
( r
R
)2]
(5.6)
where
R is the radius of the pipe;
r is the cylindrical coordinates.
This is a convenient form for the velocity profile since Uav can be
determined easily from the flow rate information. As stated before, the
maximum velocity occurs at the centreline and is determined from 5.6
by substituting r = 0,
Umax = 2Uav (5.7)
Therefore, the velocity profile in fully developed laminar flow in
a pipe is parabolic with a maximum at the centerline and minimum
(zero) at the pipe wall.
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5.1.3 The Governing Equations
The motion of a viscous fluid is governed by the Navier-Stokes system
of partial differential equations. They are derived by the differential
equation of motion combined with the conservation of mass equation.
In vector notation, for an incompressible fluid they can be written as
∇ · Ū = 0, (5.8)
ρ
(
∂Ū
∂t
+ Ū · ∇Ū
)
= −∇p+ ρḡ +∇ ·
[
τ
]
(5.9)
where
ρ is the fluid density;
Ū = (u, v, w) is the velocity vector;
p is the pressure;[
τ
]
is the shear stress tensor.
Equation 5.8 is the continuity equation and implies that the mass
flux for a volume element must be equal to zero. Equation 5.9 is a set of
three equations (one for each dimension) that describes linear momen-
tum conservation. Its left hand side (LHS) represent the acceleration of
the fluid, while the right hand side (RHS) describes pressure, viscous
stress and other body forces. This system consist of four equations
and four unknown variables (u, v, w, p), therefore the problem is ‘well-
posed’in mathematical terms. Anyhow, to fully describe the motion
of fluid flow, for a specific problem, the Partial Differential Equations
(PDEs) of 5.8 and 5.9 must be complemented with the appropriate
boundary and initial conditions.
5.1.4 Boundary conditions
The most common boundary conditions ‘BC’are the Dirichlet and the
Neumann boundary conditions. The former specifies the values that a
variable takes along a boundary while the latter specifies the derivatives
of a variable. Common boundaries to fluid flow are the walls confining
the fluid and the inlet/outlet boundaries. At the wall we shall require
that the tangential component of the velocity of the viscous fluid be
zero, which is a result of friction between the fluid and the wall due to
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viscosity. This is known as the no-slip condition, which is a Dirichlet
condition on the velocity:
Ūwall = 0̄ (5.10)
Similarly, since there is no mass transfer across the walls, a purely
kinematical consequence is that the normal component of fluid velocity,
relative to the wall, must be zero there (this represents a Neumann BC):
∂Ū
∂n
∣∣∣∣
wall
= 0 (5.11)
For CFD simulations, the inlet and the outlet conditions are generally
specified by velocity, mass flow rate or pressure. Usually, velocity and
mass flow rate conditions are inlet conditions, while pressure conditions
are commonly specified at the outlet.
5.1.5 Limitations of the analytical method
The equations of fluid mechanics - which have been known for over a
century - are solvable for a limited number of flows only. The known
solutions are extremely useful in helping to understand fluid flow but
seldom can they be used directly in engineering analysis or design.
The governing equations of fluid flow are highly non-linear and impos-
sible to solve analytically for complex geometries, so the engineers have
been forced to use other approaches. A alternative or complementary
method came with the birth of electronic computers and today, thanks
to their ever increasing computing capability it is possible to find so-
lutions for problems that seemed unsolvable. Nowadays, solution of
the equations of fluid mechanics on computers has become paramount:
this field is known as computational fluid dynamics ‘CFD’.
5.2 The Finite Element Method
As mentioned in the previous section, flows and related phenomena can
be described by PDEs which cannot be solved analytically except in
special, simple cases. To obtain an approximate solution numerically,
we have to use a discretization method which approximates the differ-
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ential equations by a system of algebraic equations, which can then be
solved with numerical computation. The approximations are applied
to small domains in space and/or time so the numerical solution pro-
vides results at discrete locations in space and time. The accuracy of
the solutions is dependent on the quality of the discretizations used.
There exist many approaches, the most important of which are: finite
difference (FD), finite volume (FV) and finite element (FE) methods.
This section provide a brief introduction to the finite element method
(FEM).
The main idea of the Finite Element Method is to divide the do-
main of the problem into a set of discrete volumes or finite elements
which form a grid, and then approximate PDEs locally for each ele-
ments . The unknown field variable is expressed in terms of assumed
approximating functions within each element of the grid (see Fig.5.3).
The approximating functions, also known as interpolation functions,
are defined in terms of the value of the field variables at the specified
points called nodes or nodal points. Nodes lie on the element bound-
aries where adjacent elements are supposed to be connected. For the
finite elements representation of a problem, the nodal values of the
field variable become the new unknowns. Once these unknowns are
found, the interpolation functions define the field variable throughout
the assemblage of elements.
The many advantage of the FEM is that it doesn’t need the grid to
be structured unlike FD methods where the mesh elements are of uni-
form size: this allow to handle very complex geometry too. The down-
side is that it is mathematically complex compared to other methods
such as FV method, another common numerical method often used for
fluid flow problems.
5.3 CFD in COMSOL
CFD simulations were run with the software COMSOL Multiphysics R©
(Version 5.0) and its CFD module. COMSOL is based on the Finite
Element Method (see Sec. 5.2), which is well suited for fluid flow
problems in complex geometry such as that of the venous chamber
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Figure 5.3: Example of 1D finite element approximation; a continuous
function is approximated using piecewise linear functions in each sub-
domain/element [67].
of the ‘cassette’. In COMSOL it is possible to create 1D, 2D, 2D-
axisymmetric and 3D models, where the geometry, physics (equations
and boundary conditions) and the mesh can be defined, all without the
need for any additional software. COMSOL also includes various study
options (such as solver methods) and post processing alternatives.
5.3.1 Geometry
Given the complex shape of the venous chamber and its lack of sym-
metry, it was decided to perform simulations using the original 3D
geometry (see Fig.5.4), in order to investigate the 3D nature of flow in-
side it. This results in a substantial increase both in computational cost
and process time compared with the use of a 2D geometry but it also
allow to obtain a better accuracy in the reconstruction of phenomena
such as recirculation bubbles and stagnation points.
5.3.2 Blood Parameters
Blood physical properties for uraemic patients were obtained in agree-
ment with the Scientific Affairs Department (SA Dept.).
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Figure 5.4: Entire geometry of the Venous Chamber.
• Blood density : blood density depends on plasma density and
hematocrit according to Eq. 5.12, derived from [15].
ρb = ρp · (1−H) + 1090 ·H (5.12)
The values of hematocrit and plasma density were suggested by
the SA Dept. and are summed in Tab. 5.2. Using that values it
Table 5.2: Values for hematocrit and plasma viscosity for uraemic patients,
T = 37◦C
Parameter Value
H 32 %
ρp 1025 Kg/m
3
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is obtained
ρb = 1045.8 Kg/m
3
• Blood viscosity : as stated in Sec.2.2.2, blood acts as a non-Newtonian
fluid with shear-thinning property; in order to model blood vis-
cosity the non-Newtonian Carreau-Yasuda model (see Eq.2.3) was
chosen (it is already implemented in COMSOL’s CFD module).
Parameters λ, n, a were obtained from [27], the value of µ0 was
gained from [14] and the value for µ∞ from [40]. All their values
are listed in Tab.5.3 and the resulting graph is shown in Figure
5.5.
Table 5.3: Parameters for the Carreau-Yasuda model
Parameter Value
λ 10.03 sec
n 0.344
a 2
µ0 0.0384 Pa·s
µ∞ 4.01 · 10−3 Pa·s
Figure 5.5: Viscosity as a function of shear rate for chosen parameter
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5.3.3 Physics and Boundary conditions
COMSOL’s CFD module gives the option to model laminar as well as
turbulent flow with already implemented physics models. The Reynolds
number in the inlet duct was calculated from Eq.5.1 to be below 400, so
that the flow is laminar. The incompressible Navier-Stokes equations
(Eq.5.9) coupled with the corresponding continuity equation (Eq.5.8)
were used to solve for the velocity and pressure fields.
The initial and boundary conditions are defined as follow:
• Initial Conditions : the initial conditions inside the venous cham-
ber were defined as a zero velocity field and a pressure of 6666 Pa,
which corresponds to 50 mmHg, that is a standard pressure value
within the venous chamber during a normal dialysis treatment.
• Inlet Condition: the available data useful to describe the inlet
condition is the volumetric flow rate on the area A1 (ref. Fig.5.7)
that is Q1=300
mL
min
= 5·10−6 m3
s
. In order to simplify the model of
the venous chamber, it was chosen to first carry out a simulation
of only the inlet duct (highlighted in blue in Fig.5.6 and Fig.5.7)
so as to obtain the value of Umax,in in the section Ain. From this
value, using Eq.5.7 it is possible to get the value of the average
speed in the section Uav,in, which is then set as the parameter for
the laminar inflow. Moreover, using Eq.5.13 derived from [37], it
is possible to calculate the value of the entrance length (le,lam) for
laminar flow and Re>50, which is also defined as an inlet BC.
le,lam
d
= 0.06 ·Re (5.13)
The inlet duct separated from the venous chamber is shown in
Fig.5.8. The obtained value for Uav,in, Rein and le,lam are summed
in Tab.5.4.
• Outlet Condition: at the outlet a condition of pressure was set.
The pressure value was obtained by experimental tests in dialysis
condition and is reported below.
Pout = 5332Pa
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Figure 5.6: Model of the Venous Chamber, highlighted in blue the inlet
duct.
Figure 5.7: Zoom on the inlet duct, indicated sections ‘1’and ‘in’.
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Figure 5.8: Schematic of only the inlet duct.
Table 5.4: Parameters value in section ‘in’
Parameter Value
Uav,in 0.378 m/sec
Rein 366
le,lam 0.1 m
• BCs at the wall : for the rigid walls surrounding the venous cham-
ber were set a no-slip condition.
5.3.4 Meshing
A simple free tetrahedral mesh was used. A 2D model mesh analysis
was made where the maximum dimension of the mesh elements was
decreased with the aim to find a fine enough mesh where no change
in a quantity of interest occurred for any additional decrease in the
dimension, or until the variations were negligible. The chosen quantity
of interest was the y velocity component v evaluated in 16 aligned
points at a certain distance from the outlet duct (see Fig.5.9).
As a result of the mesh refinement study data analysis, mesh pa-
rameter for the complete 3D model listed in tab.5.5 were obtained.
5.3.5 Studies and post-processing
The CFD studies of the venous chamber of the new cassette aim to ver-
ify the effectiveness of its design. According to what was mentioned in
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Figure 5.9: 2D model used for the mesh refinement study; red dots represent
the 16 points at which the y velocity component was evaluated.
Table 5.5: Chosen mesh parameters
Parameter Value
Maximum element size 0.7 mm
Minimum element size 0.4 mm
Maximum element growth rate 1.45
Curvature factor 0.45
Resolution of narrow regions 0.8
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section 2.3 and 2.4, the results obtained from the numerical simulation
are analysed with focus on:
1. Presence of a well-streamlined flow and of recirculation zones that
limit the presence of stagnation points which promote blood co-
agulation;
2. Absence of viscous shear stress higher than τpa (τpa = 8 Pa): if
this condition is satisfied, both platelet activation that facilitate
coagulation and shear stress that induce hemolysis are averted;
3. Absence of pressure drop higer than ∆P (∆P = 22 · 106 Pa) that
produce red cells trauma;
4. Absence of shear rate lower than the threshold value γ̇t (γ̇t =
20s−1) which favour coagulation.
Chapter 6
Results and Conclusions
In the following chapter, the results obtained from the CFD simulation
are reported and discussed, considering their correlation with the func-
tionality of the venous chamber. The final section proposes the con-
clusion of this thesis work and presents possible future developments
that could improve the quality of the results obtained.
6.1 Velocity Field
The results for the blood velocity field can be observed in Figure 6.1
and Figure 6.2. The maximum velocity is obviously found in the centre
of the inlet duct and its magnitude is 0.754 m/s. The velocity vectors
(red arrows) highlight the presence of a strong flow recirculation, in
accordance with our expectations and with preliminary in-vitro tests
performed in the company laboratories but not presented in this docu-
ment. This result is also confirmed by the streamlines shown in Figure
6.3. Figure 6.4 is a close up of the recirculation zone and offers a clearer
view of the flows that develop in this area. With regard to the velocity
field in the upper zone of the venous chamber, the results obtained are
satisfactory. They indicate a well-streamlined flow structure and the
presence of recirculation region which introduces fluid mixing. On the
other hand, Figure 6.5 highlight the presence, in the lower region, of
two zones at low flow speed which must be analysed in depth.
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(a) Plane passes through the centreline of the inlet duct.
(b) Plane passes through the centreline of the outlet duct.
Figure 6.1: Velocity field profile on x-y planes.
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Figure 6.2: Velocity vectors profile on different x-z planes.
Figure 6.3: Streamlines plot.
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Figure 6.4: Focus on the recirculation area near the inlet surface.
Figure 6.5: Focus on the velocity plot in the lower region of the venous
chamber; the blue colour stays for 0 m/s, the red one for 0.003 m/s.
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6.2 Viscous Stress
As stated in section 2.3 and 2.4, viscous shear stress higher than 8 Pa
would promote platelet activation, which enhance blood coagulation.
Furthermore, stresses greater than 150 Pa would produce high levels
of hemolysis. Concerning these two phenomena, the drip chamber of
the cassette will be considered efficient if viscous stressed inside it are
lower than the threshold value for platelet activation. This way, both
hemolysis and coagulation are avoided. Considering the fact that dur-
ing the flow the higher shear stresses are found at the wall, Figure 6.6
represent the contour of the total wall shear stress (WSS), associating
the red color to high stress and dark blue to low stress. Clearly, the
highest WSS are found in the inlet region where the maximum velocity
gradient are found. The wall shear stress magnitude was also measured
along a surface line passing through the point where the highest stress
was found and the result can be viewed in the line graph in Figure 6.8.
The maximum value of the wall shear stress is 3.64 Pa, significantly
below the threshold value of 8 Pa, and quite similar to typical values
in normal circulation (1-3 Pa). Based on the achievements of the CFD
simulation, the new design of the venous chamber is considered efficient
regarding to the viscous stress.
(a) Isometric view.
Figure 6.6: Contour plot of the wall shear stress.
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(b) Top view.
(c) Front view.
Figure 6.6: Contour plot of the wall shear stress.
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(d) Rear view.
Figure 6.6: Contour plot of the wall shear stress.
Figure 6.7: Contour plot of the wall shear stress in the outlet region.
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Figure 6.8: Wall shear stress magnitude as a function of arc length.
6.3 Pressure
As highlighted in section 2.3, pressure drops higher than ∆P = 22 ·106
Pa produce hemolysis due to yield stress of red cell membrane being
exceeded. The knowledge of negative pressure gradients that blood en-
counters in its flowing through the venous chamber is of paramount im-
portance. Figure 6.9 represents the x-y planes in which the maximum
(Pmax = 8127 Pa) and minimum (Pmin = 7998 Pa) are found. Taking
into account the preferential direction of the flow, we measured pres-
sure and the relative gradients along two surface lines passing through
the zones where the maximum gradients are found. Results can be seen
in the line graphs in Figure 6.10 and Figure 6.11. The magnitude of
the rate of change of pressure is evaluated based on the velocity which
the red cells undergo the pressure gradient. The combined analysis of
both pressure gradient and velocity magnitude yields to a maximum
rate of change of pressure of 20940 Pa/s in the inlet region and of
4600 Pa/s in the outlet region. The corresponding graph are shown in
Figure 6.12. Since the maximum allowable ∆P that produce no red
blood cells damages is 22 · 106 Pa, we can affirm that the pressure field
that is generated by the blood flow inside the venous chamber fulfil the
requirements.
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(a) Plane passes through the point of maximum pressure.
(b) Plane passes through the point of minimum pressure.
Figure 6.9: Pressure field in x-y planes.
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(a) Pressure magnitude.
(b) Pressure gradient.
Figure 6.10: Pressure magnitude and gradient as a function of arc length in
the inlet region.
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(a) Pressure magnitude.
(b) Pressure gradient.
Figure 6.11: Pressure magnitude and gradient as a function of y-coordinate
in the outlet region.
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(a) Inlet region.
(b) Outlet region.
Figure 6.12: Pressure drop magnitude in the inlet and outlet regions.
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Figure 6.13: Shear rate magnitude plotted on a surface passing through the
centerline of the inlet duct.
6.4 Shear Rate
Results from shear rate analysis are shown in Figure 6.13 and 6.14.
Obviously the maximum shear rate is found on the upper wall of the
venous chamber, near the inlet duct, on which blood impacts with a
higher velocity. The maximum value of the shear rate is 1147 s−1. But
what matters for the purpose of this study are shear rates below the
threshold value γ̇t = 20s
−1 that could promote coagulation. We expect
to find them in the two zones at low flow speed in the bottom part of
the venous chamber, which have already been highlighted in Figure 6.5.
Figure 6.15 shows the shear rate on that surface plotted together with
the streamlines. From the analysis of the streamlines, the presence
of a preferential direction of the flow is clearly seen. Blood that is
located in the two zones near the inferior edges lies outside of it and it
is in a region of very low shear rate. The synergy between these two
conditions suggests the possible presence of aggregation between cells
that promote clotting.
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Figure 6.14: Shear rate magnitude plotted on a surface passing through the
centerline of the outlet duct.
Figure 6.15: Streamlines and shear rate magnitude zoomed on a surface
passing through the centerline of the outlet duct.
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6.5 Conclusions and possible future works
The ultimate aim of this thesis work was the evaluation of the fluid
dynamic performances of the custom drip chamber of the Bellco cap-
tive disposable device. To achieve this goal, firstly the currently used
cassette and its main components were shown, their relative functions
were pointed pout and materials with which the cassette is manufac-
tured were specified. This introduction was necessary in order to show
the new design of the disposable. The development of a new layout
of the cassette started the last year: the fluid dynamic analysis of its
venous chamber is part of this project. Subsequently, we have listed
the various geometric considerations that led to the revision of the ve-
nous chamber structure and we gave reason for the choices we made
regarding the selection of new materials. The productive process by
which the new cassette shall be manufactured imposed all the above-
mentioned modifications. The new disposable shall be co-molded: this
will ensure a considerable reduction of both manufacturing times and
costs and it will guarantee a higher process robustness. Ultimately,
we focused on the drip chamber: a fluid dynamic simulation has been
carried out, using the FEM software COMSOL Multiphysics R©. The
results obtained were analyzed focusing on the velocity and pressure
fields and on the corresponding shear rate and shear stress generated.
These are the most relevant fluid dynamic parameters for the presence
or absence of phenomena such as blood hemolysis and clotting, that
are the major problems that could manifest during an extracorporeal
dialysis treatment. For this reason, the venous chamber is defined as
fluid-dynamically efficient if the flows which develop inside it do not
contribute to the occurrence of the two above-named phenomena. Re-
sults showed the presence of a well-streamlined flow combined with a re-
circulation zone that favors fluid mixing in the upper part of the venous
chamber. In the lower region, close to the bottom edge, two areas of low
velocity were highlighted. This result, analysed together the stream-
lines plot, suggested the possible presence of stagnation points which
can promote coagulation. For that reason, we made some changes to
the geometric layout of the drip chamber (bottom edges have been
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rounded). The fluid dynamic efficiency of the proposed modification
will be tested as soon as the supplier will provide us with the CAD
model. Shear stress and pressure drop rate were calculated to be be-
low the threshold value both for the presence of hemolysis and platelet
activation that favor coagulation.
Eventually, the proposed simulation can be considered as pilot in-
vestigation. First, the numerical results must be supported by in-vitro
tests, which will provide a quantitative measure of venous chamber ef-
ficiency. Secondly, to acquire a more precise understanding of the flows
that develop inside the venous chamber during a dialysis treatment, a
time dependent simulation should be carried out, so as to take account
of the pulsatile flow originated by the peristaltic pumps. Finally, the
presence of the filter on the outlet duct must be considered and its
effects on the flow should be tested.
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